Fwd: Stop Senate Bill 930 Euthanasia

Please, please share asap.Hope to see you Jan 16, info follows. 

From: "Sheila M Furey, MD from Sheila's Newsletter" <sheilamfureymd@substack.com>

Date: January 8, 2023 at 2:03:28 PM EST
To: triciastall@gmail.com
Subject: Stop Senate Bill 930 Euthanasia
Reply-To: "Sheila M Furey, MD from Sheila's Newsletter" 



Call Sen. Hashmi, Demand she withdraw her bill.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

	Open in app or online Stop Senate Bill 930 Euthanasia Call Sen. Hashmi, Demand she withdraw her bill. Sheila M Furey, MD Jan 8   Cross-post   Good Day Friends, Thank you for helping us reach our goal of 100 people on our Rumble channel. Let's kick it out of the ballpark to reach 200. Today, we need to stop Senate Bill 930. This bill grants the "healthcare" cartel the authority to kill you. This is not about death with "dignity" or support in dying or whatever catch phrase they want to spin. It is plainly and simply about manipulating, coercing, forcing a person to die via a pill or injection. Sen. Ghazala Hashmi (804-698-7510) has introduced Senate Bill 930-Medical Aid in Dying. You can change the words but it all comes down to murder. This bill is not about aid and comfort in dying. This bill is about the medical cartel conspiring to kill you and your family members. Please click on the above bill to read. Then call her office 804-698-7510 every day until she pulls this bill. Share this with every friend, church member and every member in our Veterans groups. Further, we need to ensure that Sen. Hashmi never holds public office again. How many of you had loves ones in the hospital dying of Covid and you fought day and night to save their lives? How many of you fought hospital administration and doctors that wanted to place your loved ones on a DO NOT RESUSCITATE (DNR) order? I have taken your phone calls and walked with you as your fought and prayed. Your loved ones are alive because you fought the biggest cartel in the world. You fought against the genocidal system that saw your loved one as simply "too old, too frail, too sick" to receive or continue treatment. Sadly, many lost loved-ones because our corrupt medical system chose not to offer safe effective low-cost life saving medications, but expensive (hospital bonus) dangerous medications that led to kidney failure and death. We can look at this from all kinds of moral perspectives, which there are countless and God is watching us. For today, let us simply look at this as a FREEDOM issue. You have a right to life and the government should not interfere with your right to life. The government should not have any role in hastening the end of your life. We are not to be reduced to productive vs. unproductive citizens. The medical-government-military cartel controls the hospitals, your doctors-paid employees, the pharmacies and they want to control you. This evaluation is completed by a member of the healthcare cartel that views you as a burden. You have a terminal illness. Who determines terminal? Many people have terminal illnesses and live many years. Who determines your competence to make this decision? A social worker? Who determines quality or quantity of life? The doctors with the needle? The doctors with the pill? The doctor who gets a bonus for providing "quality" healthcare? The over-burden staff who just want a day off? As always, follow the money. The advocates for Dying with Dignity and other organization are the happy recipients of grants (your tax dollars) and donations that are used to pay their salaries rather than provide care and treatment. Link This is not a slippery slope. This is downhill slide on black ice. We need only to look to our neighbor to the north. In Canada, you can be euthanized for Covid-19 (even though safe, low-cost treatment is available), mental illness, poverty and being a disabled veteran. Yes, Canada wants to tell you that you have a civic duty to die. I am not making this up. The Canadian government has gone so far as to create a coloring book for children in order to normalize this process. Link Veterans in Canada refer to the Triple D: delay, deny and dead veterans. We are well aware of the lack of care that our veterans receive here in the United States. Are we any different that our neighbor to the north? LINK LINK Please contact Sen. Hashmi 804-698-7510 and tell her to withdraw her bill. Tell her your story, every day. Join the VAMFA as we continue to educate and advocate for you and your family. Please join us on January 16 to rally at the Capitol Bell Tower in Richmond to stop the deadly shot. Join our next Zoom call on January 10th at 8 pm. Subscribe God blessing to each of you, Sheila M. Furey, MD   Cross-post     Like Comment Share   © 2023 Sheila M Furey, MD 548 Market Street PMB 72296, San Francisco, CA 94104 Unsubscribe

Wall Street Breakfast: The Week Ahead

Inflation will be in the spotlight next week with the CPI report for December due out on January 12. The headline consumer price index reading for December is expected to cool to +6.7% from +7.1% in November and be up 0.1% on a month-over-month comparison. Core CPI is forecast to be up 5.6% and up 0.2% month-over-month. Bank of America expects both core goods and energy prices to have declined again in December, but food inflation and core services inflation to have remained stickier. The focus from market watchers will be if the CPI update alters the consensus view that the Federal Reserve will hike interest rates by 50 points in February and another 25 points in March before going on hold at a terminal rate of 5.0% to 5.25%. The corporate calendar will have its first busy week of the year with the ICR Conference in Orlando and JPMorgan Healthcare Conference in San Francisco expected to see waves of earnings pre-announcements and guidance updates. Meanwhile, the earnings season officially kicks off on Friday with major banks and financial institutions stepping into the earnings confessional. Wells Fargo (WFC), JPMorgan Chase (JPM), Morgan Stanley (MS), Citigroup (C) and PNC Financial Services Group (PNC) are all scheduled to release quarterly results. Also watch the airline sector with monthly traffic reports due in and Delta Air Lines (DAL) to lead off the earnings season at the end of the week.

	Read in Browser
Welcome to the Sunday edition of Wall Street Breakfast, which previews events for investors to watch during the upcoming week. If you want to receive this a day earlier, follow Stocks to Watch and select the option to receive email notifications. Top News Inflation will be in the spotlight next week with the CPI report for December due out on January 12. The headline consumer price index reading for December is expected to cool to +6.7% from +7.1% in November and be up 0.1% on a month-over-month comparison. Core CPI is forecast to be up 5.6% and up 0.2% month-over-month. Bank of America expects both core goods and energy prices to have declined again in December, but food inflation and core services inflation to have remained stickier. The focus from market watchers will be if the CPI update alters the consensus view that the Federal Reserve will hike interest rates by 50 points in February and another 25 points in March before going on hold at a terminal rate of 5.0% to 5.25%. The corporate calendar will have its first busy week of the year with the ICR Conference in Orlando and JPMorgan Healthcare Conference in San Francisco expected to see waves of earnings pre-announcements and guidance updates. Meanwhile, the earnings season officially kicks off on Friday with major banks and financial institutions stepping into the earnings confessional. Wells Fargo (WFC), JPMorgan Chase (JPM), Morgan Stanley (MS), Citigroup (C) and PNC Financial Services Group (PNC) are all scheduled to release quarterly results. Also watch the airline sector with monthly traffic reports due in and Delta Air Lines (DAL) to lead off the earnings season at the end of the week. Featured Read Now: 10 Top Stocks for 2023 Start the year strong with an exclusive Top 10 Stocks for 2023 report from our Head of Quant, Steven Cress. In 2022, his top 10 stock picks outperformed the S&P 500 by 12%, and included Exxon (+77%) and Cigna Corp (+45%).* Now's your chance to get early access to his top picks for 2023. Read the report when you join Premium - now 50% off for your first year! Get winning insights for any investment at this special introductory price. Go Premium now * Returns calculated 1/4/22 - 12/21/22. Past performance is no guarantee of future results. Seeking Alpha does not take account of your objectives or financial situation. Earnings Earnings spotlight: Monday, January 9 - Jefferies (NYSE:JEF), PriceSmart (PSMT), and Tilray (TLRY). Earnings spotlight: Tuesday, January 10 - Albertsons Companies (NYSE:ACI) and Bed Bath & Beyond (NASDAQ:BBBY). Earnings spotlight: Wednesday, January 11 - KB Home (NYSE:KBH). Earnings spotlight: Friday, January 13 - UnitedHealth Group (UNH), JPMorgan Chase (JPM), Bank of America (BAC), Wells Fargo (WFC), BlackRock (BLK), Citigroup (C), Bank of New York (BK), and Delta Air Lines (DAL). IPOs IPO watch: Rhodium Enterprises (RHDM) and Skyward Specialty Insurance Group (SKWD) could price their IPOs and start trading next week. IPO lockup periods expire for blocks of shares of Nano Labs (NA), ILAG (NASDAQ:ILAG), and Netcapital (NCPL). All three stocks trade below their IPO pricing levels. Outlook ICR Preview: The biggest conference of the year takes place in Miami with ICR running from January 9 through 11. Analysts thinks the conference could lead to some key earnings pre-announcements and guidance updates. The presentations will give investors and analysts another chance to hear how retailers navigated through inventory and promotional pressure during the holiday season. Boot Barn (BOOT) already released its preliminary results for the holiday quarter, but many more retailers are expected to post updates. MKM Partners expects a "respectable, yet not great, pace of sales growth this holiday season." As part of its preview, BMO Capital Markets and JPMorgan both circled Lululemon Athletica (NASDAQ:LULU) as a company that could raise guidance at ICR. American Eagle Outfitters (NYSE:AEO), Urban Outfitters (URBN), Macy's (NYSE:M), Five Below (FIVE), On Holding (ONON), and Planet Fitness (PLNT) are some of the stocks that could see share price jolts off of ICR updates. In the restaurant sector, Shake Shack's (NYSE:SHAK) ICR update is seen potentially being a catalyst if the unit development and sales momentum updates are solid. Meanwhile, Nordstrom (JWN) and Best Buy (BBY) have timed their holiday sales releases during ICR in the past. If there is one central theme to watch at ICR, BMO Capital analyst Siegel said it will be the merits of a clean inventory balance versus the pricing power erosion it cost to get there. Bank earnings preview: Major U.S. banks will kick off the earnings season with investors set to focus sharply on credit card delinquencies, the level of bad loan provision, and the read on the mortgage industry. JPMorgan expects the big banks to show continued solid net interest income growth but slower than Q3, led by sharply higher rates and good loan growth. Consumer credit cards trends are expected to show a slowdown. Evercore forecasts investment banking will be down ~60% year-over-year for the quarter, while trading could be up around 10%. On the credit front, the firm sees expect higher credit costs due to some loan growth and a softer outlook for the economy plus some banks taking mark to market hits on some leveraged loans. Meanwhile, Bank of America is looking past earnings for a clearing event for the sector in the form of a credit cycle, re-steepening in the Treasury yield curve, or soft landing for the economy before fund managers revisit the group. In the near term, higher-than-expected interest rates are said to pose a significant risk to the outlook for credit quality, loan growth and net interest margins. Ahead of the rush of earnings reports from major banks, Wells Fargo analyst Mike Mayo highlighted Bank of America (BAC) as the top banking pick for 2023 and thinks U.S. Bancorp and PNC Financial (PNC) are also best in class. Events Corporate events: Arrowhead Pharmaceuticals (NASDAQ:ARWR) will present topline data from the Sequoia Phase 2 study evaluating fazirsiran and provide an outline of a Phase 3 study on January 9. Sutro Biopharma (STRO) will also host a conference call and webcast to present data from its Phase 1 dose-expansion trial and a registrational path forward for STRO-002. Genius Group Limited (NYSE:GNS) will host a virtual investor meeting on January 10 to provide an update on the business and its subsidiaries. Shareholders with Jack Creek Investment Corp. (NASDAQ:JCIC) will vote on January 12 on the SPAC deal to take Bridger Aerospace public. The aerial firefighting company is expected to be called Bridger Aerospace Group Holdings and be listed on the NASDAQ Capital Market under the ticker symbol BAER. Check out Seeking Alpha's Catalyst Watch for more events scheduled for next week. Notable conferences: The ICR Conference is not the only blockbuster of the week with the JPMorgan Healthcare conference in San Francisco expected to dominate the healthcare sector with presentations scheduled from dozens of major players, including Bristol Myers Squibb (BMY), Centene (CNC), Merck (MRK), and Walgreen Boots Alliance (NASDAQ:WBA). The JPM conference has been the setting for M&A announcements in healthcare in the past. Investors could also expect some notable updates at the Needham Growth Conference from a long list of companies that includes Petco (WOOF), TrueCar (TRUE), Sportradar (NASDAQ:SRAD), and Upwork (UPWK). Stocks Barron's mentions: Philip Morris International (PM) gets the nod from the publication this week as a stock that looks like a buy. Recent deals made by the tobacco multinational are said to have re-invigorated the bull case. For starters, the November acquisition of Swedish Match is seen further cementing Philip Morris' global leadership in oral nicotine and add to the reduced-risk product portfolio of what it calls reduced-risk products. Meanwhile, the deal with Altria (MO) to nab the rights to sell Philip Morris' flagship IQOS product in the U.S. is notable as marking PM's first return to the domestic market since the two companies split in 2008. The upshot is that Philip Morris (PM) could have a longer and brighter future than many investors had feared. Sources: EDGAR, Bloomberg, CNBC, Reuters Seeking Alpha's Wall Street Breakfast Podcast Seeking Alpha's Wall Street Breakfast podcast brings you all the news you need to know for your market day. Released by 8:00 AM ET each morning, it is a quick listen that you can put on as you get ready to start your working day.
Download Seeking Alpha for your Phone or Tablet Want More Ideas? Our best ideas → Stock Ideas ETF's Investing Ideas → ETF Ideas Dividend stocks ideas → Dividend Ideas This email was sent to you because you signed up to receive Wall Street Breakfast. If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe. Sent by Seeking Alpha, 234 5th Ave, 5 floor, New York, NY 10001